Filing status
- Accounts due
- 30 September 2027
- Last accounts
- 31 December 2025
- Conf. stmt due
- 28 May 2027
- Last conf. stmt
- 14 May 2026
Novo Nordisk Research and Development UK Limited
- Incorporated
- 14 May 2014 (12 years)
- Previously known as
- Novo Nordisk Research Centre Oxford Limited (until 2 February 2026)Ziylo Ltd (until 14 June 2022)
- Industry
- Research and experimental development on biotechnology (72110)
- Directors
- Mishal PatelTore Karlsson
- Owned by
- Novo Nordisk A/s
- Accounts type
- Small
- Region
- South East
- Address
- Innovation Building Roosevelt DriveOld Road CampusOxfordOX3 7FZ
Officers 3 active
Officer details are public data from the Companies House register.
Robinson, Elizabeth
Secretary · Appointed 15 May 2025
Patel, Mishal
Director · Appointed 4 May 2025
British
Born March 1983 (43)
Karlsson, Tore
Director · Appointed 8 November 2022
Danish
Born September 1980 (46)
Officer history (15 former)
6 August 2026
Resigned Rasmussen, Mads Frederik as Director
1 May 2026
Resigned Haynes, William Geoffrey as Director
10 September 2025
Resigned Conde-Knape, Avelina Karin as Director
15 May 2025
Appointed Robinson, Elizabeth as Secretary
4 May 2025
Appointed Patel, Mishal as Director
15 October 2024
Resigned O'Flynn, Matthew as Secretary
8 November 2022
Appointed Conde-Knape, Avelina Karin as Director
8 November 2022
8 November 2022
Appointed Rasmussen, Mads Frederik as Director
8 November 2022
Appointed Karlsson, Tore as Director
8 November 2022
8 November 2022
22 November 2021
22 November 2021
Appointed Haynes, William Geoffrey as Director
19 November 2021
Resigned Schindler, Marcus as Director
24 October 2018
Resigned Petersen, Jacob Sten as Director
24 October 2018
24 October 2018
16 August 2018
Resigned Davis, Anthony, Professor as Director
16 August 2018
Resigned Smart, Thomas as Secretary
16 August 2018
Appointed Schindler, Marcus as Director
16 August 2018
16 August 2018
Resigned Chapman, Andrew, Dr as Director
16 August 2018
Resigned Destecroix, Harry, Dr as Director
16 August 2018
Appointed Petersen, Jacob Sten as Director
16 August 2018
Appointed O'Flynn, Matthew as Secretary
16 August 2018
Resigned Macdonald, Keith as Director
13 December 2017
Appointed Chapman, Andrew, Dr as Director
17 November 2014
Appointed Macdonald, Keith as Director
17 November 2014
Appointed Davis, Anthony, Professor as Director
14 May 2014
Appointed Smart, Thomas as Secretary
14 May 2014
Appointed Destecroix, Harry, Dr as Director
14 May 2014
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Novo Nordisk A/s
Corporate entity · Notified 16 August 2018
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Corporation
Reg. no. N/A
Former controllers (2)
16 August 2018
Ceased Novo Nordisk Region Europe A/s — Owns 75–100% of shares
14 September 2017
Ceased Harry Destecroix — Owns 25–50% of shares
Filings 107
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 28 September 2026 | Accounts for a small company | 31 December 2025 | ||
| 10 August 2026 | Termination of appointment of a director | |||
| 19 May 2026 | Confirmation statement with updates | 14 May 2026 | ||
| 5 May 2026 | Termination of appointment of a director | |||
| 2 February 2026 | Certificate of change of name |
Some other companies at this address
Other companies in this industry
Sandwich
Newcastle Upon Tyne
Edinburgh
By trade and location
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →